GLP-1s. Specialty costs. Emerging therapies. PBM scrutiny. Policy shifts. The forces shaping pharmacy benefits aren't slowing down. Join us on December 9 for a webinar featuring CarelonRx industry experts Andrew Davis and Alex Bolorchi, PharmD, as they cut through the noise to examine the biggest lessons from 2026 and what employers, brokers, and consultants should be watching as they prepare for 2027. Register here